March 2024, New poster is released by the Fungicide Resistance Action Committee (FRAC), revealing the inclusion of Group 54, Benzoxaboroles, in the…
Tag:
Sandoz
-
-
CompaniesIntellectual Property (IP)Patent LitigationPatentsSandoz
Sandoz and Teva Invalidate Patent and SPC of Blockbuster Apixaban
by adminby adminSummary : EP 1,427,415 was assigned to BMS and is set to expire on September 17, 2022. On May 19, 2026, the…
-
CompaniesNovartis
Novartis signs initial agreement with Carisma Therapeutics for the manufacturing of HER 2 targeted CAR-M cell therapy
by adminby adminSummary : Novartis has signed an initial agreement with Carisma Therapeutics, a biopharmaceutical pioneer in engineered macrophage-based therapeutics, to manufacture the HER…
-
CompaniesGlobal MarketNovartis
Syncona announces sale of portfolio company to Novartis
by adminby adminSynopsis : Syncona – a company focused on founding, building and funding global leaders in life science – has announced the sale…
-
-
CompaniesGlobal MarketNovartis
Financials Indicate Novartis’ Sandoz Division Could Be a Tough Sell
by adminby adminSynopsis : Novartis reported its full-year financials this week for 2021, and overall, the news was good. Full-year net sales grew 4%,…
-
Agrochemicals
Amgen Wins its Second Patent of the year, Delaying Samsung’s Enbrel Biosim until 2029.
by adminby adminSummary – A U.S. District Court has ruled in favor of Amgen in a patent litigation case involving the drug Enbrel, preventing…